Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



AstraZeneca PLC Facing China Probe Risks, Shares Drop

November 07, 2024
Are Options Traders Betting on a Big Move in AstraZeneca AZN Stock? Yahoo Finance reported that AstraZeneca PLC (AZN) is facing potential risks from a China probe, causing its shares to drop. The investigation could have a significant impact on the company's operations and overall stock performance. Optas LLC, a stockholder, has boosted its stock holdings in AstraZeneca PLC, indicating confidence in the company's long-term prospects. However, despite this, AstraZeneca's stock has trailed the market. Investors are advised to seek professional guidance from Stocks Prognosis to make informed decisions on the forecasted movement of AstraZeneca's shares.
If you want to leave a comment, then you need Login or Register





Other data for AZN

Related data

AZNAugust 25, 2025AstraZeneca's Breakthrough Study on Advanced Biliary Tract Cancer  ~1 min.

AstraZeneca PLC has recently announced groundbreaking results from their new study on advanced biliary tract cancer, showing promising potential for a new treatment option in cancer care....


AZNAugust 22, 2025ASTRAZENECA PLC Hits Price Target Forecast with 20.55% Profit  ~1 min.

On January 23, 2025, QuantWave issued a long signal for ASTRAZENECA PLC with a price of 67.17 $. The forecast proved to be accurate as the stock reached the target price of 80....


AZNAugust 22, 2025ASTRAZENECA PLC Stock Hits QuantWave's Price Target Forecast with 14.63% Profit  ~1 min.

ASTRAZENECA PLC stock has successfully reached the price target forecast provided by QuantWave, resulting in a profitable outcome for investors....


AZNAugust 20, 2025ASTRAZENECA PLC Stock Hits Price Target, Yielding 14.58% Profit - QuantWave Prediction Success  ~2 min.

On June 18, 2025, QuantWave issued a long forecast signal for ASTRAZENECA PLC when the stock was trading at $70.27....


AZNAugust 20, 2025ASTRAZENECA PLC Hits Price Target Forecast with 16.44% Profit: A Win for QuantWave  ~1 min.

ASTRAZENECA PLC, one of the leading pharmaceutical companies, has seen its stock price hit the forecasted target with a substantial 16....


AZNAugust 20, 2025ASTRAZENECA PLC Stock Hits Price Target, Generating 13.99% Profit for QuantWave Users  ~2 min.

On July 2, 2025, QuantWave, an automated forecasting platform, issued a price target forecast for ASTRAZENECA PLC with a long signal at a price of 70.64 $....


AZNAugust 20, 2025ASTRAZENECA PLC Hits Price Target Forecast with a 15.91% Profit  ~1 min.

QuantWave's forecast signal for ASTRAZENECA PLC on June 20, 2025, proved to be accurate as the stock reached the predicted target on August 20, 2025. The price at the time of the signal was 69....


AZNAugust 20, 2025ASTRAZENECA PLC Hits QuantWave Forecast Target with 15.71% Profit  ~1 min.

On June 26, 2025, QuantWave's automated forecasting platform issued a long signal for ASTRAZENECA PLC with a price target of $80.52. The stock was trading at $69....


AZNAugust 20, 2025ASTRAZENECA PLC Stock Hits Forecast Price Target with Profit of 13.46%: QuantWave Analysis  ~2 min.

ASTRAZENECA PLC's stock recently achieved the price target forecasted by QuantWave with a profit of 13.46%....


AZNAugust 20, 2025ASTRAZENECA PLC Hits Price Target Forecast with 16.75% Profit  ~1 min.

On July 3, 2025, QuantWave's forecast signal indicated a long position for ASTRAZENECA PLC when the stock was priced at 68.97 $. Today, on August 20, 2025, the price of ASTRAZENECA PLC reached 80....


AZNJanuary 15, 2025AstraZeneca PLC Faces Class Action Lawsuit Deadline for Stockholders: Robbins LLP Issues Reminder  ~2 min.

Robbins LLP, a global investor rights law firm, is reminding stockholders of AstraZeneca PLC (AZN) about the upcoming lead plaintiff deadline in the class action lawsuit against the company....


AZNNovember 24, 2024AstraZeneca PLC Receives Acquisition Offer from Pathstone Holdings LLC  ~1 min.

Pathstone Holdings LLC has announced its intention to acquire AstraZeneca PLC, a leading pharmaceutical company specializing in immunotherapy....


MNSTMarch 20, 2025Monster Beverage Corporation Rejects Mini-Tender Offer by TRC Capital Investment Corporation  ~2 min.

Monster Beverage Corporation, a leading energy drink manufacturer, has recommended its stockholders to reject a recent mini-tender offer proposed by TRC Capital Investment Corporation....


LUMNJanuary 31, 2025Stockholders of Lumen Technologies Faced with Dilemma as Shares Plummet  ~1 min.

According to recent reports, Lumen Technologies Inc. (NYSE:LUMN) experienced a significant 14.4% decrease in its stock value....


AZNOctober 30, 2024AstraZeneca Faces Investigation in China: Some Information for Investors  ~2 min.

AstraZeneca PLC, a multinational pharmaceutical company, is facing an investigation in China regarding the actions of its president....